Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 530,904 |
|
|||||
| News | (1) | ||||||
| Day High | 9.80 | Low High |
|||||
| Day Low | 7.9604 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SciSparc Ltd | SPRC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.15 | 1.92% | 7.96 | 19:50:53 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.60 | 7.9604 | 9.80 | 7.96 | 7.81 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,039 | 530,904 | $ 8.63 | $ 4,579,447 | - | 2.80 - 34.58 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:47 | 10 | $ 8.00 | USD |
SciSparc Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.16M | 521.09k | - | 1.35M | -2.59M | -4.97 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SciSparc News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SPRC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.13 | 14.2199 | 7.81 | 10.02 | 4,245,625 | -0.17 | -2.09% |
| 1 Month | 5.43 | 14.2199 | 4.18 | 8.19 | 2,663,140 | 2.53 | 46.59% |
| 3 Months | 3.8844 | 14.2199 | 2.80 | 5.83 | 5,628,904 | 4.08 | 104.92% |
| 6 Months | 17.16 | 23.66 | 2.80 | 6.30 | 3,051,552 | -9.20 | -53.61% |
| 1 Year | 27.56 | 34.58 | 2.80 | 9.36 | 1,868,595 | -19.60 | -71.12% |
| 3 Years | 182.00 | 184.08 | 2.80 | 21.06 | 1,633,162 | -174.04 | -95.63% |
| 5 Years | 182.00 | 184.08 | 2.80 | 21.06 | 1,633,162 | -174.04 | -95.63% |
SciSparc Description
| SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority. |
